PARP Inhibitor Olaparib Causes No Potentiation of the Bleomycin Effect in VERO Cells, Even in the Presence of Pooled ATM, DNA-PK, and LigIV Inhibitors

por Perini, Valentina, Schacke, Michelle, Liddle, Pablo, Vilchez-Larrea, Salomé, Keszenman, Deborah J., Lafon-Hughes, Laura
Publicado 2020

Evaluation of Histone Deacetylase Inhibitors as Radiosensitizers for Proton and Light Ion Radiotherapy

por Johnson, Alicia M., Bennett, Paula V., Sanidad, Katherine Z., Hoang, Anthony, Jardine, James H., Keszenman, Deborah J., Wilson, Paul F.
Publicado 2021